Status:
COMPLETED
A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions:
Coronary Artery Stenosis
Coronary Heart Disease
Eligibility:
All Genders
30-75 years
Phase:
PHASE4
Brief Summary
This study investigates the effective power of angina pectoris after Quick-Acting Heart Reliever and isosorbide dinitrate interventing respectively the patients with moderate coronary stenosis for six...
Detailed Description
Blood-quickening stasis-transforming medicinal of Chinese medicinal can ameliorate clinical symptoms of coronary artery disease. Quick-Acting Heart Reliever is one of blood-quickening stasis-transform...
Eligibility Criteria
Inclusion
- Male or female subjects 30-75 years of age
- Angina or CAD patient
- Diameter stenosis 50-75% in at least one main coronary artery (Confirmed by coronary arteriography or coronary CT angiography)
- Not received percutaneous coronary intervention(PCI)
- Heart blood stasis obstruction syndrome according to TCM syndrome differentiation
- Provide written informed consent.
Exclusion
- Heart transplant or history of CABG or history of percutaneous transluminal coronary angioplasty (PTCA) with a drug-eluting stent.
- Left ventricular ejection fraction \< 35%
- Acute myocardial infarction within 4 weeks prior to inclusion
- The contractive pressure \> 160 mmHg or diastolic pressure \>100 mmHg
- Severe valvular heart disease
- Insulin-dependent diabetes mellitus
- Serious heart, lung, liver, kidney and brain or other primary complications
- Mental patients
- Diagnosed or suspected tumor
- Allergic persons
- Pregnant, breastfeeding, or intends to become pregnant during the course of the study (females only)
- Patients not willing to or not able to give the informed consent to participate in the study
- The patients who are attending other clinical trial
- The person maybe loss for some reason such as work or life condition according to the investigator's judgement
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01513070
Start Date
April 1 2012
End Date
June 1 2014
Last Update
August 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100053